共 50 条
Modern Therapeutic Approaches for Noninfectious Ocular Diseases Involving Inflammation
被引:19
|作者:
Ratay, Michelle L.
[1
]
Bellotti, Elena
[2
]
Gottardi, Riccardo
[3
]
Little, Steven R.
[4
]
机构:
[1] Univ Pittsburgh, Dept Bioengn, 427 Benedum Hall 3700 OHara St, Pittsburgh, PA 15261 USA
[2] Univ Pittsburgh, Dept Chem Engn, 427 Benedum Hall 3700 OHara St, Pittsburgh, PA 15261 USA
[3] Ri MED Fdn, Dept Orthoped Surg, Dept Chem Engn, 427 Benedum Hall 3700 OHara St, Pittsburgh, PA 15261 USA
[4] McGowan Inst Regenerat Med, Dept Pharmaceut Sci, Dept Immunol, Dept Chem Engn,Dept Bioengn,Dept Ophthalmol, 940 Benedum Hall 3700 OHara St, Pittsburgh, PA 15261 USA
基金:
美国国家卫生研究院;
关键词:
age-related macular degeneration;
drug delivery;
dry eye disease;
therapeutics;
uveitis;
DRY EYE DISEASE;
DRUG-DELIVERY SYSTEMS;
REGULATORY T-CELLS;
MEIBOMIAN GLAND DYSFUNCTION;
LOW-DOSE CYCLOSPORINE;
EMBRYONIC STEM-CELLS;
LONG-TERM EFFICACY;
MACULAR DEGENERATION;
MYCOPHENOLATE-MOFETIL;
FLUOCINOLONE ACETONIDE;
D O I:
10.1002/adhm.201700733
中图分类号:
R318 [生物医学工程];
学科分类号:
0831 ;
摘要:
Dry eye disease, age-related macular degeneration, and uveitis are ocular diseases that significantly affect the quality of life of millions of people each year. In these diseases, the action of chemokines, proinflammatory cytokines, and immune cells drives a local inflammatory response that results in ocular tissue damage. Multiple therapeutic strategies are developed to either address the symptoms or abate the underlying cause of these diseases. Herein, the challenges to deliver drugs to the relevant location in the eye for each of these diseases are reviewed along with current and innovative therapeutic approaches that attempt to restore homeostasis within the ocular microenvironment.
引用
收藏
页数:23
相关论文